AmirAli Talasaz
AmirAli Talasaz is the co-founder and co-chief executive officer of Guardant Health, a biotech company focusing on cancer diagnostics. He has highlighted the impact of blood-based tests on increasing colorectal cancer screening rates, aiming to make screening more accessible and improve early detection among populations that are less likely to undergo traditional testing methods.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 8.00 | 0.61% | +0% | 331,002,651 | 2,018,309 | $21,000,000 | 128,049$ |
| Totals | 1 | 331,002,651 | 2,018,309 | $21,000,000 | 128,049$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
AmirAli Talasaz is the co-founder and co-CEO of Guardant Health, emphasizing the need for accessible colorectal cancer screening.
8